Category:
Active Pharmaceutical Ingredients
CAS NO:
NA
Standard:
In-house Standards,
Suitable for allergic rhinitis with and without allergic conjunctivitis (seasonal and perennial). Symptomatic treatment of chronic idiopathic urticaria.
Ebastine Tablets are non-sedating antihistamine formulations used for allergy management. The core manufacturing process involves granulation and compression of Ebastine API with molecular formula C25H30N2O2 (CAS No. 83796-16-3).
Contraindicated in patients with severe hepatic impairment or hypersensitivity to Ebastine. Store tablets below 25°C in a dry, light-resistant environment to maintain stability.